增强腹部CT肾上腺肿块自动检测与测量的深度学习模型
本研究基于415例增强腹部CT(155例有肾上腺肿块、260例无肿块)开发并验证全自动深度学习模型,采用U-Net分割网络进行肿块检测与测量。外部测试集995例中AUC为0.94,敏感度89.6%、特异度96.9%;50例内部测试集中预测直径与CT及病理测量直径的ICC分别为0.848和0.855。
要点
- 模型在外部测试集中特异度达96.9%,阳性预测值为59.7%,用于筛查时需注意假阳性可能。
- 模型对肾上腺肿块直径预测与病理测量ICC为0.855,可用于随访和术前评估的辅助测量。
- 外部测试集中肾上腺肿块真实发生率为4.8%,提醒日常阅片时对该区域保持主动排查意识。
核心结论
- 该深度学习模型可在增强腹部CT中较准确检测并测量肾上腺肿块,有望提高检出率并促进早期处理。
- 模型外部测试AUC为0.94,准确性96.6%,对肾上腺肿块检测具有较好泛化能力。
研究设计与样本
- 回顾性研究,开发队列415例增强腹部CT,含155例有肾上腺肿块、260例无肿块,中位年龄40岁,男性206例。
- 采用预训练分割模型自动生成肾上腺掩膜,经人工修正后训练基于U-Net的分割网络。
- 外部测试集995例用于验证肿块检测,内部测试集2(50例)用于验证尺寸测量。
- 外部测试集反映真实世界中肾上腺肿块发生率4.8%,由影像学评估确定,无病理证实。
关键影像表现/征象
- 内部测试集1(42例)中肾上腺肿块分类AUC为0.99(95% CI 0.92–1.0),平均Dice系数0.812。
- 外部测试集中模型识别肿块的敏感度为89.6%(95% CI 77.3–96.5%)。
- 内部测试集2中模型识别出50个肾上腺肿块中的44个。
诊断标准与关键数值
- 外部测试集肿块检测AUC为0.94(95% CI 0.93–0.96)。
- 外部测试集检测特异度96.9%(95% CI 95.6–97.9%),准确性96.6%(95% CI 95.3–97.5%)。
- 外部测试集阳性预测值59.7%(95% CI 50.6–68.2%)。
- 预测直径与CT测量直径ICC为0.848(95% CI 0.723–0.917),与病理测量直径ICC为0.855(95% CI 0.735–0.921)。
临床应用与阅片要点
- 该模型可用于筛查、随访及术前评估场景中辅助识别易被漏诊的肾上腺肿块。
- 模型自动生成肾上腺区域掩膜并分割肿块,可作为第二阅读器提示可疑病灶位置。
- 注意阳性预测值59.7%,阳性提示仍需结合轴位及冠状位图像人工复核确认。
局限性
- 外部测试集肿块由影像学评估确定,无病理证实,可能存在诊断标准偏倚。
- 该研究为回顾性设计,模型在真实前瞻性临床流程中的表现尚需验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Adrenal tumors can be functional or malignant, yet they are often overlooked in abdominal CT. This study aimed to develop and validate a fully automated deep learning model for adrenal mass detection and measurement in contrast-enhanced abdominal CT.
MATERIALS AND METHODS: This retrospective study included 415 CT scans with (n = 155) and without (n = 260) adrenal masses for model development (median age, 40 years; 206 men). Adrenal gland masks were automatically generated using a pretrained segmentation model, and adrenal mass masks were manually refined to train a U-Net-based segmentation network. Two secondary test sets were used for validating mass detection (external test set, n = 995) and size measurement (internal test set 2, n = 50). The external test set reflects a real-world incidence of adrenal masses (4.8%) as determined by radiologic evaluation without pathologic confirmation. The model performance was evaluated using the area under the receiver operating characteristic curve (AUC) for adrenal mass detection and the intraclass correlation coefficient (ICC) for adrenal mass measurement.
RESULTS: In the internal test set 1 (n = 42), the AUC for classifying adrenal mass was 0.99 (95% confidence interval [CI]: 0.92-1.0), with an average Dice score of 0.812. The model achieved an AUC of 0.94 (95% CI: 0.93-0.96) with sensitivity, specificity, accuracy, and positive predictive value of 89.6%, 96.9%, 96.6%, and 59.7% (95% CI: 77.3-96.5%, 95.6-97.9%, 95.3-97.5%, and 50.6-68.2%, respectively), respectively, in the external test set. The model identified 44 of 50 adrenal masses in internal test 2. The ICCs of the predicted diameter were 0.848 (95% CI: 0.723-0.917) and 0.855 (95% CI: 0.735-0.921) for the CT-measured and pathologically measured diameters, respectively.
CONCLUSION: The proposed deep learning model accurately detected and measured adrenal masses in abdominal CT. The model has the potential to improve detection rates of adrenal lesions and facilitate their early management.
CLINICAL RELEVANCE STATEMENT: The proposed deep learning model can detect adrenal masses often missed by radiologists and accurately estimate their size, potentially improving patient management in screening, follow-up, and preoperative settings.
KEY POINTS: Adrenal masses, which may be functional or malignant, are frequently missed on abdominal CT, leading to delays in appropriate management. A deep learning model can accurately detect the adrenal masses (accuracy 96.6%) and predict the size similar to the sizes measured in CT and surgical specimens (ICC 0.848-0.855). The proposed DL algorithm may help clinicians in various clinical settings, including screening, follow-up, and preoperative evaluation of adrenal masses.
引用
- Kim, Lee, Seo, et al. Automated deep learning for detection and measurement of adrenal masses in contrast-enhanced abdominal CT. Eur Radiol. 2026. PMID: 41609765. doi:10.1007/s00330-025-12314-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。